New treatment approved for drug-resistant tuberculosis

The US Food and Drug Administration approved a new treatment for highly drug-resistant tuberculosis, offering new hope in the fight against the world's...

Posted: Aug 16, 2019 3:29 AM
Updated: Aug 16, 2019 3:39 AM

The US Food and Drug Administration approved a new treatment for highly drug-resistant tuberculosis, offering new hope in the fight against the world's most deadly infectious disease.

TB most affects the lungs and can be particularly difficult to treat. Drug-resistant strains are on the increase due to incomplete and challenging courses of treatment that last for more than 18 months.

Pretomanid, a compound developed by the nonprofit TB Alliance and approved by the FDA on Wednesday, forms part of a three-drug regimen that people can take orally over six months. It treats two drug-resistant strains of the disease, XDR-TB and MDR-TB.

"Until very recently, people infected with highly drug-resistant TB had poor treatment options and a poor prognosis," said Dr. Francesca Conradie, principal investigator of the trial. "This new regimen provides hope with nine out of 10 patients achieving culture negative status at six months post-treatment with this short, all-oral regimen."

Tuberculosis claims 4,400 lives a day worldwide. According to the World Health Organization, highly drug-resistant strains account for more than 500,000 of the 10 million new cases of the disease each year and are found in 127 countries around the world.

Scientists tested safety and effectiveness of Pretomanid, which is taken together with bedaquiline -- approved as a TB treatment in 2012 -- and linezolid, an antibiotic, in patients in South Africa.

Of the 107 patients who were evaluated six months after the end of therapy, 95 (89%) had a successful outcome.

South Africa's burden of the airborne disease is particularly high, as a high incidence of HIV works with drug-resistant TB, weakening immune systems to make people more susceptible.

"The bacterium that causes tuberculosis can develop resistance to the antibiotics used to treat it. Multidrug-resistant TB and extensively drug-resistant TB are public health threats due to limited treatment options," FDA Principal Deputy Commissioner Amy Abernethy said in a statement.

Pretomanid is expected to be available in the United States by the end of this year, with the European Medicines Agency and the World Health Organization highly likely to follow suit and approve the treatment.

Pretomanid is only the third new anti-TB drug approved for use by the FDA in more than 40 years.

Treatment of highly drug-resistant TB has traditionally been complex and lengthy, with patients taking a combination of as many as eight antibiotics, some involving daily injections, for 18 months or longer. Some older regimens can cause patients to lose their hearing.

Dr. Mel Spigelman, president and CEO of TB Alliance, said the new "regimen will hopefully provide a shorter, more easily manageable and highly efficacious treatment for those in need."

"FDA approval of this treatment represents a victory for the people suffering from these highly drug-resistant forms of the world's deadliest infectious disease."

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 155597

Reported Deaths: 2208
CountyCasesDeaths
Multnomah31877528
Washington21211212
Marion18468285
Clackamas13380175
Lane10258126
Jackson8395112
Umatilla765982
Deschutes595259
Yamhill378364
Linn359056
Malheur335158
Polk306442
Klamath279155
Douglas247454
Benton234416
Josephine234050
Jefferson195828
Coos149119
Union128419
Columbia126521
Wasco122126
Lincoln113220
Hood River106929
Morrow104914
Clatsop7756
Crook77518
Baker6567
Curry4296
Tillamook4142
Lake3766
Harney2736
Grant2231
Wallowa1424
Gilliam531
Sherman530
Wheeler221
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 3566914

Reported Deaths: 52158
CountyCasesDeaths
Los Angeles119192321435
Riverside2894503767
San Bernardino2866072874
Orange2612203917
San Diego2600913284
Santa Clara1106211777
Kern102627827
Fresno953931443
Sacramento932811472
Alameda806681242
Ventura77623844
San Joaquin665691101
Contra Costa62248681
Stanislaus56132946
Tulare47784758
Monterey42138328
San Mateo38998515
San Francisco34260412
Santa Barbara31805411
Solano30024164
Merced28915397
Sonoma28141298
Imperial26903591
Kings21955218
Placer19763232
San Luis Obispo19612227
Madera15467209
Santa Cruz14588183
Marin13136197
Yolo12834185
Shasta10985174
Butte10962160
El Dorado9095100
Napa903869
Sutter884597
San Benito576759
Yuba573337
Lassen560119
Tehama508152
Nevada396074
Tuolumne394659
Mendocino379643
Amador346341
Humboldt318033
Lake315641
Glenn222523
Colusa212813
Calaveras190547
Siskiyou174014
Inyo128737
Mono12114
Del Norte9875
Plumas6536
Modoc4524
Mariposa3957
Trinity3675
Sierra990
Alpine810
Unassigned00
Medford
Clear
60° wxIcon
Hi: 62° Lo: 30°
Feels Like: 60°
Brookings
Partly Cloudy
52° wxIcon
Hi: 57° Lo: 37°
Feels Like: 52°
Medford
Clear
60° wxIcon
Hi: 42° Lo: 18°
Feels Like: 60°
Medford
Partly Cloudy
60° wxIcon
Hi: 61° Lo: 30°
Feels Like: 60°
Klamath Falls
Clear
53° wxIcon
Hi: 50° Lo: 23°
Feels Like: 53°
Very mild start to March
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events